Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $755.35 | 10 | 80.2% |
| Education | $186.94 | 2 | 19.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $230.03 | 4 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $121.92 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $119.70 | 1 | $0 (2022) |
| Genentech USA, Inc. | $109.48 | 1 | $0 (2019) |
| Seagen Inc. | $102.40 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 | $0 (2020) |
| AVEO Pharmaceuticals, Inc. | $86.99 | 1 | $0 (2022) |
| ADC Therapeutics America, Inc. | $58.65 | 1 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $13.17 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.17 | 1 | Apellis Pharmaceuticals, Inc. ($13.17) |
| 2022 | $510.70 | 5 | E.R. Squibb & Sons, L.L.C. ($201.61) |
| 2021 | $58.65 | 1 | ADC Therapeutics America, Inc. ($58.65) |
| 2020 | $99.95 | 1 | SANOFI-AVENTIS U.S. LLC ($99.95) |
| 2019 | $259.82 | 4 | Alexion Pharmaceuticals, Inc. ($121.92) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2023 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: Hematology | ||||||
| 06/01/2022 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: ONC | ||||||
| 04/21/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $102.40 | General |
| Category: Oncology | ||||||
| 04/07/2022 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $86.99 | General |
| Category: Oncology | ||||||
| 04/06/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $94.50 | General |
| Category: Oncology | ||||||
| 03/31/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $107.11 | General |
| 10/22/2021 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $58.65 | General |
| 11/06/2020 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 07/16/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.92 | General |
| 07/12/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Oncology | ||||||
| 07/12/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $12.01 | General |
| 03/26/2019 | Genentech USA, Inc. | Alecensa (Biological) | Food and Beverage | In-kind items and services | $109.48 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 394 | 678 | $150,429 | $55,988 |
| 2022 | 3 | 73 | 112 | $20,378 | $7,653 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 65 | 122 | $29,890 | $12,918 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 116 | $26,912 | $10,420 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 157 | $25,434 | $9,206 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 65 | 105 | $18,060 | $6,913 | 38.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 53 | 64 | $14,912 | $5,350 | 35.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 49 | $14,602 | $4,793 | 32.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $10,512 | $3,090 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $6,792 | $2,050 | 30.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 11 | 17 | $3,315 | $1,248 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 40 | 54 | $9,288 | $3,907 | 42.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 44 | $7,128 | $2,365 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $3,962 | $1,381 | 34.9% |
About Dr. Jordan Ciuro, M.D
Dr. Jordan Ciuro, M.D is a Medical Oncology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1851741789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jordan Ciuro, M.D has received a total of $942.29 in payments from pharmaceutical and medical device companies, with $13.17 received in 2023. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($755.35).
As a Medicare-enrolled provider, Ciuro has provided services to 467 Medicare beneficiaries, totaling 790 services with total Medicare billing of $63,641. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program, Hematology & Oncology
- Location Augusta, GA
- Active Since 06/22/2016
- Last Updated 03/11/2024
- Taxonomy Code 207RX0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851741789
Products in Payments
- Trodelvy (Drug) $119.70
- OPDIVO (Biological) $110.91
- Alecensa (Biological) $109.48
- ADCETRIS (Biological) $102.40
- JEVTANA (Drug) $99.95
- FOTIVDA (Drug) $86.99
- Empaveli (Drug) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Augusta
Shou-Ching Tang, M.d, M.D
Medical Oncology — Payments: $38,182
Ambreen Ijaz, M.d, M.D
Medical Oncology — Payments: $18,298
Andrew Hertler, Md, MD
Medical Oncology — Payments: $4,691
Dr. Ashanda Esdaille, M.d, M.D
Medical Oncology — Payments: $847.18
Sneha Purvey
Medical Oncology — Payments: $529.41
Malinda West, M.d, M.D
Medical Oncology — Payments: $175.48